18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
View More
Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment
Study to evaluate impact of ArteraAI on clinical decision-making for prostate cancer
FDA does not approve talazoparib plus enzalutamide for non-HRR gene mutated mCRPC
Ultrasound imaging system now available to guide nonsurgical urology procedures
CPT 49186 vs 38780: Coding retroperitoneal mass excision